New Cannabis Group Will Help Ground Policy in Science and Patient Experience
A cannabis medicine group policy is working to ground federal discussions in science and patient experience. This approach aims to improve access to cannabinoid therapies. It ensures policies reflect both clinical evidence and real-world patient…
High Tide Joins U.S. National Compassionate Care Council | HITI Stock News
Compassionate care frameworks are critical pathways for patients needing medical cannabis for serious conditions. These frameworks support improved access and consistent product standards. Efforts to reform medical cannabis policy focus on evidence-based…
US Cannabis Rescheduling: A Victory or a Federal Trap?
US cannabis rescheduling federal policy marks a major shift with complex implications for patient access. This change could funnel cannabis through FDA approval pathways, risking disruption of state medical programs. Understanding these federal policy…
Federal Order Does Not Legalize Recreational Marijuana, Senator Clarifies
The cannabis rescheduling executive order shifts marijuana from Schedule I to Schedule III, easing research restrictions but not legalizing recreational use. This federal policy clarification highlights that full legalization requires Congressional…
